What Are the Facial Features of Turner Syndrome?

Turner Syndrome (TS) is a chromosomal condition affecting females, resulting from the complete or partial absence of one of the two X chromosomes. This genetic anomaly leads to a set of distinct physical characteristics, known as the phenotype, often involving the head, face, and neck. These physical markers are frequently the first indicators that lead healthcare providers to suspect the condition and are important for early recognition.

Identifying the Key Physical Features

The craniofacial profile in individuals with Turner Syndrome often presents with several identifiable characteristics. A prominent feature is the neck region, where a low posterior hairline is common, often extending down the nape of the neck. This is frequently accompanied by pterygium colli, known as a webbed neck, which is a broad fold of skin running from the shoulders to the sides of the neck.

Features around the eyes include epicanthal folds, which are skin folds covering the inner corner of the eyes, and a tendency for the eyelids to droop, a condition called ptosis. Eye alignment issues, such as strabismus, are also seen more frequently. The ears may be low-set on the head, appear prominent, or be rotated slightly backward.

The structure of the jaw and mouth also shows specific patterns. Many individuals exhibit micrognathia, which describes a small lower jaw and chin. Cephalometric studies indicate that both the maxilla (upper jaw) and the mandible (lower jaw) can be retrognathic, meaning they are positioned further back than average. This jaw structure often contributes to a high-arched palate and can lead to dental crowding or malocclusion.

The Genetic Basis for Facial Development

Turner Syndrome most frequently results from Monosomy X, a karyotype designated 45, X, where one X chromosome is completely absent in all cells. In other cases, a person may have mosaicism, meaning some cells have the 45, X pattern while others may be normal (46, XX) or have a structurally altered X chromosome. This loss of genetic material disrupts normal developmental pathways.

The physical features are largely attributed to the haploinsufficiency of genes located on the X chromosome that escape X-inactivation. Haploinsufficiency means that a single copy of these genes is insufficient for normal development. While the SHOX gene is strongly linked to the characteristic short stature and some skeletal abnormalities, other genes likely influence the soft tissue and bone development of the face and neck.

The distinct neck and hairline features are a direct consequence of lymphatic system abnormalities during the fetal period. The chromosomal change can cause lymphedema, which is the accumulation of fluid, particularly in the head and neck region during gestation. As this fluid is later reabsorbed, it leaves behind the excess skin and tissue that forms the webbed neck and contributes to the low posterior hairline observed at birth.

Role of Facial Features in Early Diagnosis

The recognition of these visible characteristics plays a role in the early diagnosis of Turner Syndrome. Features such as swelling (lymphedema) of the hands and feet or the presence of a webbed neck at birth can immediately raise clinical suspicion. This physical evidence serves as the trigger for necessary laboratory testing.

The definitive diagnosis is confirmed through karyotyping, a genetic test that examines the chromosomes to identify the 45, X or mosaic pattern. Recognizing the facial and neck features, particularly in infancy or early childhood, allows physicians to order this genetic testing much sooner than if they only waited for the onset of short stature or delayed puberty.

An early diagnosis allows for timely therapeutic intervention and comprehensive monitoring. For instance, growth hormone therapy can be initiated early to improve final adult height, which is a common concern in TS. Early detection also ensures proactive screening for associated health risks, such as congenital heart defects, which are often present but not visibly apparent without specialized cardiac imaging.